Calliditas Therapeutics AB Overview

Calliditas Therapeutics AB Gross Profit

Gross Profit analysis for CALT.

Quarterly Gross Profit

$506.33M

↑ 98.43% YoY

As of Jun 30, 2024

Annual Gross Profit (TTM)

$1.50B

↑ 34.31% YoY

Trailing 12 months ending Jun 30, 2024

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin